How to Help Your Patients Find Clonidine XR in Stock: A Provider's Guide

Your Patients Need Clonidine XR — and They're Calling Your Office for Help

If you prescribe Clonidine XR (Kapvay/generic Clonidine ER) for ADHD, you've likely heard from frustrated patients — and their parents — who cannot get the medication filled. The extended-release formulation has faced ongoing supply disruptions, and the burden of finding available stock often falls back on your practice.

This guide provides a practical, step-by-step approach to help your patients locate Clonidine XR, along with clinical alternatives and workflow strategies to reduce the administrative strain on your team.

Current Availability Snapshot

As of early 2026, Clonidine Hydrochloride Extended-Release Tablets remain in limited supply:

• Generic Clonidine ER (0.1 mg, 0.2 mg tablets): Available from a reduced number of manufacturers. Supply is inconsistent — some pharmacies have stock while others cannot source it from their wholesalers.
• Brand Kapvay: Rarely available at retail pharmacies. Not a practical option for most patients.
• Onyda XR (extended-release suspension): An alternative formulation from Tris Pharma that may be available where tablets are not.
• Clonidine IR (generic/Catapres): Widely available with no shortage. Priced under $10 per month with discount cards.

For the broader context on the shortage, see our clinical briefing on the Clonidine XR shortage for prescribers.

Why Patients Can't Find Clonidine XR

Understanding the root causes helps frame the conversation with patients:

Manufacturer Discontinuations

The FDA has noted discontinuations of Clonidine ER by certain manufacturers. Fewer producers means less supply and more geographic variability in availability.

Generic Market Consolidation

The number of active generic Clonidine ER manufacturers has declined. With fewer sources, any single production disruption has a disproportionate impact on national supply.

Rising ADHD Prescription Volume

Increased ADHD diagnoses — particularly via telehealth platforms — have driven higher demand for both stimulant and non-stimulant medications. Non-stimulant agents like Clonidine XR have seen significant prescription growth.

Pharmacy Sourcing Limitations

Large chain pharmacies are often locked into exclusive wholesaler contracts, limiting their ability to source from alternative distributors. Independent pharmacies with multiple wholesaler relationships may have better success.

What Providers Can Do: 5 Actionable Steps

Step 1: Direct Patients to Medfinder

The most immediate action you can take is directing patients to Medfinder. This tool provides real-time pharmacy inventory data, allowing patients (and your staff) to identify pharmacies with Clonidine XR currently in stock.

Consider including Medfinder in your patient discharge instructions or post-visit summaries for any patient prescribed Clonidine XR. This proactive step can prevent phone calls back to your office.

Step 2: Prescribe With Pharmacy Flexibility

When writing the prescription, consider these strategies:

• Allow generic substitution. Ensure the prescription permits "substitution allowed" so pharmacists can fill with any available generic manufacturer's product.
• Include DAW 0. Dispense as written code 0 (or the equivalent in your EHR) gives the pharmacy maximum flexibility.
• Consider 90-day quantities. If the patient's insurance permits, writing for 90 days reduces the frequency of refill-related shortages and ensures a larger buffer supply.
• Send to pharmacies with known stock. If you have information about which pharmacies currently have Clonidine ER (via Medfinder or patient reports), send the electronic prescription directly to that pharmacy.

Step 3: Document a Contingency Plan

For every patient on Clonidine XR, document a shortage contingency plan in the chart. This should include:

• Preferred alternative agent (e.g., Guanfacine ER with starting dose)
• Bridge strategy (e.g., Clonidine IR at adjusted dose if ER unavailable for less than 2 weeks)
• Taper instructions (if discontinuation becomes necessary)
• Follow-up timeline (when to reassess after a switch)

Having this documented in advance means your staff can implement the plan quickly if a patient calls reporting they can't fill their prescription.

Step 4: Proactively Discuss Alternatives at Appointments

Don't wait for the pharmacy to reject the prescription. At each visit, briefly discuss the shortage situation and ensure the patient knows what to do if they can't find Clonidine XR:

• Where to search for stock (Medfinder, independent pharmacies)
• What the backup medication would be and how to request it
• Why they should never stop Clonidine abruptly (rebound hypertension risk)
• How to contact your office for a bridge prescription if needed

Step 5: Leverage Your Clinical Staff

Train medical assistants and pharmacy liaisons in your practice to:

• Check Medfinder when patients report availability issues
• Contact specialty and compounding pharmacies on behalf of patients
• Process prior authorizations proactively if an alternative agent is needed
• Communicate the contingency plan to the patient and pharmacy

This distributes the workload and prevents the prescriber from being the bottleneck in shortage management.

Alternative Agents: Quick Reference

When Clonidine XR is unavailable, these are the primary alternatives:

• Guanfacine ER (Intuniv/generic): First-line alternative. Same drug class. Once daily. Ages 6-17. Generic cost: $20-$50/month with coupons. Less sedating than Clonidine.
• Atomoxetine (Strattera/generic): SNRI mechanism. Approved for children, adolescents, and adults. Generic cost: $15-$40/month. Takes 4-6 weeks for full effect. Boxed warning for suicidal ideation in pediatric patients.
• Viloxazine ER (Qelbree): Newer SNRI. Approved for ages 6+ and adults. Brand only: $300+/month. Manufacturer copay assistance available.
• Clonidine IR (Catapres/generic): Same active ingredient, different release profile. Widely available, under $10/month. Requires dose recalculation — NOT mg-for-mg interchangeable with ER.

For a detailed clinical comparison, see our article on alternatives to Clonidine XR.

Workflow Tips for Managing the Shortage

EHR Alerts

If your EHR supports custom alerts, consider adding a medication-level note for Clonidine ER prescriptions. Something like: "Clonidine ER in limited supply. Verify pharmacy stock before sending. Contingency: see chart note dated [date]." This reminds all providers and staff at the point of prescribing.

Patient Communication Templates

Create a standardized handout or patient portal message explaining:

• The shortage is real and not the pharmacy's fault
• How to use Medfinder to find stock
• What to do if they can't find it (call the office, don't stop the medication)
• Their specific backup plan (documented in their chart)

Batch Prior Authorizations

If multiple patients may need to switch to alternatives, prepare prior authorization documentation proactively. Having the clinical justification pre-written (e.g., "Patient on Clonidine ER which is in FDA-listed shortage; switching to Guanfacine ER as clinically appropriate alternative") can speed up the process.

Final Thoughts

The Clonidine XR shortage adds complexity to ADHD management, but with structured preparation, the impact on your patients can be minimized. Direct patients to Medfinder for Providers, document contingency plans, and keep your clinical team informed.

For additional provider resources, see our article on helping patients save money on Clonidine XR and the patient-facing guide on finding Clonidine XR in stock.